THE POSSIBLE USE OF SERUM MHC CLASS-II LEVELS FOR MONITORING GRAFT-VERSUS-HOST DISEASE IN BONE-MARROW TRANSPLANT RECIPIENTS

被引：0
|
作者：
THOMPSON, S
WAREHAM, M
PEARSON, ADJ
SVILAND, L
TURNER, GA
机构：
[1] MED SCH NEWCASTLE UPON TYNE,DEPT CLIN BIOCHEM,NEWCASTLE TYNE NE2 4HH,ENGLAND
[2] MED SCH NEWCASTLE UPON TYNE,DEPT CHILD HLTH,NEWCASTLE TYNE NE2 4HH,ENGLAND
来源：
BRITISH JOURNAL OF CANCER | 1988年 / 58卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：250 / 250
页数：1
相关论文
共 50 条
  • [21] GRAFT VERSUS HOST-DISEASE IN RECIPIENTS OF SYNGENEIC BONE-MARROW
    OLSSON, L
    KIGER, N
    MATHE, G
    LANCET, 1980, 1 (8162): : 253 - 253
  • [22] THE MHC INFLUENCES ACUTE GRAFT-VERSUS-HOST DISEASE IN MHC MATCHED ADULTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    SMYTH, LA
    WITT, CS
    CHRISTIANSEN, FT
    HERRMANN, RP
    HOLLINGSWORTH, PN
    TOWNEND, DC
    EDWARD, E
    DAWKINS, RL
    BONE MARROW TRANSPLANTATION, 1993, 12 (04) : 351 - 355
  • [23] ISOAMYLASE LEVELS IN BONE-MARROW TRANSPLANT PATIENTS ARE AFFECTED BY TOTAL-BODY IRRADIATION AND NOT BY GRAFT-VERSUS-HOST DISEASE
    BRATTSTROM, C
    TOLLEMAR, J
    RINGDEN, O
    BERGSTROM, K
    TYDEN, G
    TRANSPLANT INTERNATIONAL, 1991, 4 (02) : 96 - 98
  • [24] EPIDERMAL DAMAGE IN SKIN OF ALLOGENEIC BONE-MARROW TRANSPLANT RECIPIENTS - RELATIVE IMPORTANCE OF CHEMOTHERAPY, CONDITIONING AND GRAFT-VERSUS-HOST DISEASE
    NORTON, J
    SLOANE, JP
    JOURNAL OF PATHOLOGY, 1992, 168 : A96 - A96
  • [25] GRAFT-VERSUS-HOST DISEASE IN EXPERIMENTAL AND CLINICAL BONE-MARROW TRANSPLANTATION
    TUTSCHKA, PJ
    PLASMA THERAPY & TRANSFUSION TECHNOLOGY, 1985, 6 (02): : 257 - 274
  • [26] SIGNIFICANCE OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    NAKAMURA, H
    TESHIMA, H
    HIRAOKA, A
    SHIBATA, H
    INOUE, T
    MASAOKA, T
    ACTA HAEMATOLOGICA JAPONICA, 1987, 50 (08): : 1627 - 1633
  • [27] REVERSAL OF GRAFT-VERSUS-HOST DISEASE WITH INFUSION OF AUTOLOGOUS BONE-MARROW
    RICORDI, C
    TZAKIS, AG
    ZEEVI, A
    RYBKA, WB
    DEMETRIS, AJ
    FONTES, PAC
    NALESNIK, MA
    TRUCCO, M
    UKAH, FO
    BALL, ED
    MULLEN, EE
    MARINO, IR
    FUNG, JJ
    STARZL, TE
    CELL TRANSPLANTATION, 1994, 3 (02) : 187 - 192
  • [28] THALIDOMIDE FOR GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION
    SAURAT, JH
    CAMENZIND, M
    HELG, C
    CHAPUIS, B
    LANCET, 1988, 1 (8581): : 359 - 359
  • [29] CHRONIC GRAFT-VERSUS-HOST DISEASE IN ALLOGENIC BONE-MARROW TRANSPLANTATION
    VOLCPLATZER, B
    HINTERBERGER, W
    HAUTARZT, 1984, 35 (06): : 322 - 323
  • [30] GRAFT-VERSUS-HOST DISEASE FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
    YOSHIKAWA, S
    AKAO, Y
    HIRAIWA, A
    SAO, H
    YAMAUCHI, T
    TAHARA, T
    YOSHIKAWA, H
    MATSUYAMA, K
    KIMURA, S
    KITAYAMA, S
    TANABE, S
    UNO, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 1984, 14 : 509 - 518
12345